Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human YES1 Antibodies:
anti-Mouse (Murine) YES1 Antibodies:
anti-Rat (Rattus) YES1 Antibodies:
Go to our pre-filtered search.
Human Monoclonal YES1 Primary Antibody for ELISA, WB - ABIN1724691
Reinehr, Becker, Höngen, Haüssinger: The Src family kinase Yes triggers hyperosmotic activation of the epidermal growth factor receptor and CD95. in The Journal of biological chemistry 2004
Show all 3 Pubmed References
Human Monoclonal YES1 Primary Antibody for ELISA, WB - ABIN967267
Annerén, Cowan, Melton: The Src family of tyrosine kinases is important for embryonic stem cell self-renewal. in The Journal of biological chemistry 2004
Show all 3 Pubmed References
Our results suggest that H19 (show NCKAP1 Antibodies) functions as a competitive endogenous RNA (ceRNA) by acting as a sink for miR-17-5p, revealing a potential ceRNA regulatory network involving H19 (show NCKAP1 Antibodies) and miR-17-5p with a role in the modulation of YES1 expression
c-Yes plays an important role in migration and invasion of epithelial ovarian cancer.
Up-regulation of miR (show MLXIP Antibodies)-210 inhibits hepatocellular carcinoma cell proliferation. Yes1 is a target of miR (show MLXIP Antibodies)-210 and affects cell proliferation in HCC (show FAM126A Antibodies).
findings indicate that miR (show MLXIP Antibodies)-203 induces the apoptosis of KB cells by directly targeting Yes-1, suggesting its application in anti-cancer therapeutics
Results demonstrate a unique role for Yes in phosphorylation of FAK (show PTK2 Antibodies) and in promoting PCa (show FLVCR1 Antibodies) metastasis. Therefore, phosphorylated FAK (show PTK2 Antibodies) Y861 and increased Yes expression may be predictive markers for PCa (show FLVCR1 Antibodies) metastasis.
results indicated that miR-17-5p might play a role in human ovarian cancer by up-regulating YES1 expression.
Increased YES/SFK activation might serve as a clinical biomarker for predicting tumor resistance to IGF-1R (show IGF1R Antibodies) inhibition.
YES1 and YAP (show YAP1 Antibodies) transcript levels were higher in liver metastases of patients with colon cancer after 5FU-based neoadjuvant chemotherapy.
YES kinase as a proximal glucose-specific signal in the Cdc42 (show CDC42 Antibodies)-signaling cascade.
we identified CRKL (show CRKL Antibodies)/YES as critical interrelated pathways necessary for rhabdomyosarcoma cell growth and survival and suggest a potential therapeutic role of SRC (show SRC Antibodies) family kinase inhibition in the treatment of rhabdomyosarcoma.
investigated signaling pathways in early development by comparison of the phosphoproteome of wild type embryos with Fyn (show FYN Antibodies)/Yes knockdown embryos that display specific convergence and extension cell movement defects
Ganglioside GD3 enhances invasiveness of gliomas by forming a complex with PDGFRalpha and Yes Kinase.
serum also activates TEAD-dependent transcription in a time- and dose-dependent manner and we identify Inter-alpha-inhibitor (IalphaI) as a component in serum capable of activating the Yes/YAP (show YAP1 Antibodies)/TEAD pathway
Differentiation of embryonic stem cells is driven by c-Src (show SRC Antibodies) is antagonized by c-Yes.
The antiapoptotic effect of YES1 activation in response to testicular heat insult may mediate via the regulation of extracellular signal-regulated kinase (ERK (show EPHB2 Antibodies))/metastasis-associated 1 (MTA1 (show MTA1 Antibodies)) cascade.
Results suggest that LKB1 (show STK11 Antibodies) inactivation in the context of RAS activation facilitates metastasis by inducing an SFK-dependent expansion of a prometastatic, CD24 (show CD24 Antibodies)(+) tumor subpopulation.
YAP (show YAP1 Antibodies), TEAD2 (show TEAD2 Antibodies) and Yes are highly expressed in self-renewing embryonic stem cells, and are activated by LIF (show LIF Antibodies).
eIF4E (show EIF4E Antibodies) and yes have cooperative roles in oncogenic transformation
Data show that in response to angiotensin II, the ability of ERK1/2 (show MAPK1/3 Antibodies) to remain within the cytoplasm or translocate into the nucleus is controlled by c-Src (show SRC Antibodies)/Yes/Fyn (show FYN Antibodies) or heterotrimeric G protein/PKCzeta (show PRKCZ Antibodies) signaling, respectively.
Data imply that distinct modes of spatial activation and membrane delivery, under the control of specific acylation attachment sequences and endosome sub-type requirements, define distinct properties of the three SFKs (Src (show SRC Antibodies) family kinases).
Binding of CD95 Ligand to CD95 on glioblastoma cells recruit Yes and the p85 subunit of phosphatidylinositol 3-kinase to CD95, which signal invasion via the glycogen synthase kinase 3-beta pathway and subsequent expression of matrix metalloproteinases.
This gene is the cellular homolog of the Yamaguchi sarcoma virus oncogene. The encoded protein has tyrosine kinase activity and belongs to the src family of proteins. This gene lies in close proximity to thymidylate synthase gene on chromosome 18, and a corresponding pseudogene has been found on chromosome 22.
Yamaguchi sarcoma oncogene
, cellular yes-1 protein
, proto-oncogene c-Yes
, proto-oncogene tyrosine-protein kinase YES
, tyrosine-protein kinase Yes
, protein-tyrosine kinase
, tyrosine-protein kinase yes
, viral oncogene yes-1 homolog 1
, v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1
, viral oncogene yes-1 homolog 1-like
, proto-oncogene tyrosine-protein kinase Yes-like
, proto-oncogene tyrosine-protein kinase Yes
, viral oncogene yes homolog
, c-yes proto-oncogene
, Yamagichi sarcoma viral (v-yes-1) oncogene homolog 1
, Yamaguchi sarcoma viral oncogene homolog 1